William J Chase Intellia Therapeutics, Inc. (NTLA) insider trading activity

NTLA Quotes by TradingView

William J Chase is of Intellia Therapeutics, Inc.. Currently has a direct ownership of 26,693 shares of NTLA, which is worth approximately $540,266. The most recent transaction as insider was on Jun 12, 2024, when has been sold 7,737 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 26.7K
0% 3M change
40.82% 12M change
Total Value Held $540,266

WILLIAM J CHASE Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 12 2024
BUY
Grant, award, or other acquisition
-
7,737 Added 22.47%
26,693 Common Stock
Jun 14 2023
BUY
Grant, award, or other acquisition
-
1,673 Added 8.11%
18,956 Common Stock
Apr 14 2023
BUY
Grant, award, or other acquisition
-
10,483 Added 37.75%
17,283 Common Stock

Also insider at

ABBV
AbbVie Inc. Healthcare
EVP, Finance & Administration
GRAL
GRAIL, Inc.
Director
WJC

William J Chase

North Chicago, IL

Track Institutional and Insider Activities on NTLA

Follow Intellia Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

News

Receive news related to Intellia Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NTLA